Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Microbio CoROCO:4128 -2.77%56 9-Day RSI is 22.98 as of Jul. 30, 2026. GuruFocus rates ROCO:4128 with a GF Score™ of 56/100 and a GF Value™ of NT$44.49 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 2,111 Consumer Packaged Goods companies, Microbio Co ranks better than 94.46% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-07-30), Microbio Co's 9-Day RSI is 22.98.
The industry rank for Microbio Co's 9-Day RSI or its related term are showing as below:
ROCO:4128's 9-Day RSI is ranked better than 94.46% of 2111
companies
in the Consumer Packaged Goods industry
Industry Median: 49.38
vs ROCO:4128: 22.98
Microbio Co (ROCO:4128) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Microbio Co 9-Day RSI Related Terms
ROCO:4128 vs KHC, GIS: 9-Day RSI Comparison
For the Packaged Foods subindustry, Microbio Co's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Microbio Co 9-Day RSI vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Microbio Co's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Microbio Co's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Microbio Co (ROCO:4128) has a 9-Day RSI of 22.98 as of Jul. 30, 2026. According to the industry distribution chart, Microbio Co ranks #117 out of 2111 companies in the Consumer Packaged Goods industry, placing it in the top 5.5%.
Is Microbio Co's 9-Day RSI too high?
Microbio Co's current 9-Day RSI is 22.98. The Consumer Packaged Goods industry median 9-Day RSI is 49.38. Microbio Co's value of 22.98 is 53.5% below this industry median. Based on the distribution chart, Microbio Co ranks #117 out of 2111 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Microbio Co has a GF Score™ of 56/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Microbio Co's 9-Day RSI compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Microbio Co ranks #117 out of 2111 companies for 9-Day RSI. This places Microbio Co in the top 6% of its industry — outperforming the majority of peers. The industry median 9-Day RSI is 49.38. Microbio Co's value of 22.98 is 53.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Consumer Packaged Goods company?
The median 9-Day RSI among Consumer Packaged Goods companies is 49.38, based on 2,111 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Microbio Co's current 9-Day RSI of 22.98 is 53.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Consumer Packaged Goods industry, the median 9-Day RSI is 49.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Microbio Co's current 9-Day RSI is 22.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microbio Co stock overvalued right now?
Based on GuruFocus' analysis, Microbio Co (ROCO:4128) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$44.49, compared to a current price of NT$14.05 — trading 68.4% below its estimated fair value. The current 9-Day RSI is 22.98 and 53.5% below the Consumer Packaged Goods industry median of 49.38. Microbio Co's overall GF Score™ is 56/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Microbio Co (ROCO:4128), the current 9-Day RSI is 22.98 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Microbio Co (ROCO:4128) Overvalued in 2026?
Based on GuruFocus' analysis, Microbio Co stock appears to be undervalued.
The current stock price of NT$14.05 is trading 68.4% below its estimated GF Value™ of NT$44.49.
GuruFocus considers Microbio Co to be Significantly Undervalued.
Key valuation signals for ROCO:4128:
9-Day RSI: 22.98
GF Value™: NT$44.49 vs. price of NT$14.05 (68.4% below fair value)
Industry Position: 53.5% below the Consumer Packaged Goods median (#117 of 2111)
No single metric tells the full story. See the ROCO:4128 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Microbio Co Ltd is engaged in the research and development, manufacturing, and trading of biotech drugs and dietary supplements. Its drug portfolio includes MS-20, a mixture of soybean fermentation metabolites, which improves fatigue and loss of appetite in cancer patients undergoing chemotherapy. In addition, the company also offers Lee Herb series of herbal essence drinks, Tien Chun Bao oral solutions, Herbiron oral solutions for iron deficiency, and other pharmaceutical and organic products. The company generates revenue from biotech drug research and development and the sale of dietary supplements. The majority of its revenue is generated from the sale of its dietary supplements.
56GF Score
Get the complete analysis for ROCO:4128
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4128 has been successfully added to your 
